Canada Pension Plan Investment Board Buys New Shares in Humana Inc. $HUM

Key Points

• Canada Pension Plan Investment Board purchased 171,237 Humana shares worth approximately $68 million, giving it a 0.14% stake. Institutional investors collectively own 92.38% of the company.
• Humana exceeded quarterly expectations, reporting $7.61 in adjusted earnings per share versus the $7.27 consensus estimate and $40.89 billion in revenue, up 26.2% year over year.
• Analyst sentiment is mixed: 14 analysts rate Humana a Buy, 15 a Hold and one a Sell, resulting in a consensus Hold rating and a $403.91 price target.

Canada Pension Plan Investment Board purchased a new position in shares of Humana Inc. (NYSE:HUM - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 171,237 shares of the insurance provider's stock, valued at approximately $68,019,000. Canada Pension Plan Investment Board owned 0.14% of Humana as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also added to or reduced their stakes in the company. Wilkerson Advisory Group LLC increased its holdings in Humana by 24.6% in the 2nd quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider's stock worth $66,000 after buying an additional 33 shares during the period. Bogart Wealth LLC increased its stake in shares of Humana by 192.0% in the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider's stock worth $29,000 after acquiring an additional 48 shares during the period. Fiduciary Alliance LLC raised its holdings in shares of Humana by 0.9% during the first quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider's stock worth $976,000 after purchasing an additional 49 shares during the last quarter. Sanctuary Advisors LLC raised its holdings in shares of Humana by 1.6% during the fourth quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider's stock worth $868,000 after purchasing an additional 52 shares during the last quarter. Finally, Horizon Investments LLC lifted its position in Humana by 2.5% during the fourth quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider's stock valued at $573,000 after purchasing an additional 55 shares during the period. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Price Performance

Humana stock opened at $392.72 on Friday. The company's fifty day moving average price is $385.08 and its 200 day moving average price is $287.78. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $428.88. The stock has a market capitalization of $47.16 billion, a P/E ratio of 37.15, a P/E/G ratio of 2.23 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts' consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion during the quarter, compared to analysts' expectations of $40.58 billion. During the same period in the prior year, the business posted $6.27 earnings per share. The firm's revenue for the quarter was up 26.2% on a year-over-year basis. As a group, equities research analysts anticipate that Humana Inc. will post 9.12 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have commented on HUM shares. Raymond James Financial lowered shares of Humana from an "outperform" rating to a "market perform" rating in a report on Thursday, July 30th. Guggenheim boosted their price objective on Humana from $269.00 to $471.00 and gave the company a "buy" rating in a report on Thursday, July 30th. Deutsche Bank Aktiengesellschaft assumed coverage on Humana in a research note on Thursday, July 30th. They issued a "hold" rating on the stock. Needham & Company LLC began coverage on Humana in a report on Wednesday, May 20th. They set a "buy" rating on the stock. Finally, UBS Group began coverage on Humana in a research report on Thursday, July 30th. They set a "buy" rating for the company. Fourteen analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $403.91.

About Humana

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source